AGfit-3
Clinical Evidence
and Scientific Research
on AGfit-3
AGfit-3:
Clinical Evidence and Scientific Research on AGfit-3
Clinical studies, research and scientific publications
AGfit-3 has undergone rigorous clinical trials, particularly in partnership with the University of Padua, demonstrating significant reductions in blood alcohol levels.
The combination of Silymarin, Myrica cerifera, and Bio-PQQ not only supports faster alcohol metabolism but also acts as a potent antioxidant, protecting the liver from alcohol-induced oxidative stress.
You can review our research in top scientific journals such as Nutrients for more in-depth insights.
The global market for hangover products is booming, driven by increasing demand for natural, effective remedies. As per Straits Research, the market is expected to surpass USD 9 billion by 2033, presenting a significant opportunity for innovative solutions like AGfit-3.
Discover the university study